Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
UW Scientists, Backed by Gates Foundation, Enter “Put Up or Shut Up” Phase with Portable Diagnostic
|
Luke Timmerman |
11/03/09 |
Seattle
|
|
Pulmatrix Scores $30M To Block All Sorts of Bugs That Make People Sick in the Lungs
|
Luke Timmerman |
11/02/09 |
Boston
|
|
UK’s Enigma Diagnostics to Establish U.S. Headquarters in San Diego
|
Bruce V. Bigelow |
10/27/09 |
San Diego
|
|
Omeros Accused on Eve of IPO, Seattle Genetics Trial Fails, How Much Biotechies Really Earn, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/08/09 |
Seattle
|
|
Veratect Secures $4.2M Debt
|
Luke Timmerman |
10/06/09 |
Seattle
|
|
Amazon Goes Mobile, Theraclone Inks $18M Deal, Spiration Pulls In $7M, & More Seattle-Area Deals News
|
Gregory T. Huang |
10/06/09 |
Seattle
|
|
Seattle’s Theraclone Strikes $18M Deal to Make Flu-Fighting Antibodies with Japanese Company
|
Luke Timmerman |
10/05/09 |
Seattle
|
|
It’s About Health Care, Not Health Insurance
|
Norm Wu |
09/28/09 |
Seattle
|
|
Quidel, Pulling Off a Turnaround, Predicts Record Profit on Demand for Flu Tests
|
Luke Timmerman |
09/10/09 |
San Diego
|
|
Finding HIV’s Weak Spot, Scientists at Seattle’s Theraclone and San Diego’s Scripps See Opening for New Vaccine
|
Luke Timmerman |
09/03/09 |
National
|
|
AVI Developing Swine Flu Drugs
|
Luke Timmerman |
06/22/09 |
Seattle
|
|
Sanofi CEO Bets Outside U.S., Gears Up for Flu Pandemic, and Seeks To Learn From Biotech
|
Luke Timmerman |
06/19/09 |
Seattle
|
|
UW Stem Cell Startup is Born, Global Health’s “Davos” Arrives, MDRNA Unloads Debt, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
06/18/09 |
Seattle
|
|
Sanofi-Aventis Donates 100 Million Flu Vaccine Doses to WHO at Seattle Summit
|
Luke Timmerman |
06/17/09 |
Seattle
|
|
IDRI Offers Flu Vaccine Boosters
|
Luke Timmerman |
06/11/09 |
Seattle
|
|
Pulmatrix, With One Drug for Multiple Bugs, Aims to Fundamentally Change Flu Treatment
|
Luke Timmerman |
06/09/09 |
Boston
|
|
Invest Northwest Notebook: Five of Seattle’s Next-Generation Life Sciences Innovators Seek to Adapt
|
Luke Timmerman |
03/19/09 |
Seattle
|
|
Quidel Shares Plunge on Warning
|
Bruce V. Bigelow |
03/16/09 |
San Diego
|
|
PATH, Fueled by Bill Gates’ Fortune, Builds Global Health Hothouse in Seattle
|
Luke Timmerman |
02/04/09 |
Seattle
|
|
New RNAi Drugs, Major Cutbacks at Targanta, Big Partnerships for Arqule and Archemix, & More Boston-Area Life Sciences News
|
Wade Roush |
12/24/08 |
Boston
|
|
Sermo, Taking a Page from Google, Creates Flu Tracker
|
Wade Roush |
12/22/08 |
Boston
|
|
Seattle Genetics Drug Fights Hodgkin’s, Frazier Sounds Off on Biotech Ventures, SBRI Pushes Malaria Vaccine, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
12/11/08 |
Seattle
|
|
Seattle-based Kineta, New Biotech Startup, Unveils Plan to Trigger Innate Immunity
|
Luke Timmerman |
12/09/08 |
Seattle
|
|
The Quest for a Malaria Vaccine: SBRI’s Stefan Kappe Stares Down a Leading Candidate
|
Luke Timmerman |
12/09/08 |
Seattle
|
|
PATH Invests $3M in Flu Vaccine Candidate
|
Luke Timmerman |
12/04/08 |
Seattle
|
|
Vaccine Impresario, Todd Patrick, At it Again With Immunization Against Strep Throat
|
Luke Timmerman |
11/18/08 |
Seattle
|
|
Announcing Xconomy’s First Event in Seattle: Vaccines 2.0
|
Luke Timmerman |
11/06/08 |
Seattle
|
|
Tysabri’s Roots at the “Hutch,” MediQuest Spurned by FDA, ZymoGenetics Drug Passes Test, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
11/06/08 |
Seattle
|
|
Leroy Hood, Turning 70, Still Aims to Accomplish “The Most Ambitious Things of My Career”
|
Luke Timmerman |
10/10/08 |
Seattle
|
|
Institute for Systems Biology, UW Researchers Win Bulk of $68M Grants To Study Flu, SARS
|
Luke Timmerman |
10/09/08 |
Seattle
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
